GU Cancers 2019 | Combined blockade of VEGF and PD-1 signaling in RCC

Name: Combined blockade of VEGF and PD-1 signaling in RCC
Uploaded: 2019-02-15T00:00:00Z
Duration: 1 min 45 s
Description: Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the issues involved in the combined blockade of vascular endothelial growth factor (VEGF) and programmed death 1 (PD-1) signaling in renal cell carcinoma (RCC). This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Michael Atkins • 15 Feb 2019

GU Cancers 2019

Genitourinary Cancer Kidney Cancer Checkpoint Inhibitors

Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the issues involved in the combined blockade of vascular endothelial growth factor (VEGF) and programmed death 1 (PD-1) signaling in renal cell carcinoma (RCC). This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.